Mostrar el registro sencillo del documento

dc.creatorSatici, Celal
dc.creatorAltunok, Elif Sargin
dc.creatorCalik, Mustafa
dc.creatorZuhal Cavus
dc.creatorEsatoglu, Sinem Nihal
dc.date.accessioned2020-07-29T21:25:38Z
dc.date.available2020-07-29T21:25:38Z
dc.date.created2020-06-10
dc.identifier.issn1201-9712spa
dc.identifier.otherhttps://www.ijidonline.com/article/S1201-9712(20)30473-2/fulltext#%20spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/11382
dc.format.extent6 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.publisherInternational Journal of Infectious Diseaseseng
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectPneumoniaspa
dc.subjectCURB-65spa
dc.subjectPneumonia severity indexspa
dc.subjectPrognosisspa
dc.subjectMortalityspa
dc.titlePerformance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19spa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.identifier.doihttps://doi.org/10.1016/j.ijid.2020.06.038spa
dc.description.abstractenglishObjective The aim of the study was to analyze the usefulness of CURB-65 and the pneumonia severity index (PSI) in predicting 30-day mortality in patients with COVID-19, and to identify other factors associated with higher mortality. Methods A retrospective study was performed in a pandemic hospital in Istanbul, Turkey, which included 681 laboratory-confirmed patients with COVID-19. Data on characteristics, vital signs, and laboratory parameters were recorded from electronic medical records. Receiver operating characteristic analysis was used to quantify the discriminatory abilities of the prognostic scales. Univariate and multivariate logistic regression analyses were performed to identify other predictors of mortality. Results Higher CRP levels were associated with an increased risk for mortality (OR: 1.015, 95% CI: 1.008–1.021; p < 0.001). The PSI performed significantly better than CURB-65 (AUC: 0.91, 95% CI: 0.88–0.93 vs AUC: 0.88, 95% CI: 0.85–0.90; p = 0.01), and the addition of CRP levels to PSI did not improve the performance of PSI in predicting mortality (AUC: 0.91, 95% CI: 0.88–0.93 vs AUC: 0.92, 95% CI: 0.89–0.94; p = 0.29). Conclusion In a large group of hospitalized patients with COVID-19, we found that PSI performed better than CURB-65 in predicting mortality. Adding CRP levels to PSI did not improve the 30-day mortality prediction.spa


Archivos en el documento

Thumbnail

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento